Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Indian billionaire Sunil Bharti Mittal joins BT board

(Sharecast News) - Indian billionaire Sunil Bharti Mittal is to join the board of BT Group, the UK telecoms and broadband giant said on Monday. BT said that Mittal, the founder and chair of Bharti Enterprises, and Gopal Vittal, managing director of Bharti Airtel, were joining as non-independent, non-executive directors.

Bharti currently owns a 24.5% stake in the blue chip, having acquired the holding from Patrick Drahi's Altice at the end of 2024. At the time, the stake was worth around £3.2bn, according to Reuters.

Both appointments have been made under the relationship agreement signed between Bharti and BT.

Under the terms, parent company Bharti Global has the right to nominate two directors for as long as it holds a BT interest of at least 20%.

Adam Crozier, BT chair, said Mittal and Vittal brought "significant experience and global perspectives in the telecoms industry", adding: "We look forward to their contribution to the board and future success of BT."

Mittal called BT an "iconic" business. He continued: "I look forward to working with Adam Crozier, the board and chief executive Allison Kirkby to drive forward the strategy to win in the market and deliver world-leading services for BT's customers."

As well Bharti Airtel - one of the world's biggest network provides - Mittal owns stakes in a number of telecoms and tech groups worldwide.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.